Liquidity and going-concern pressure
The company has an accumulated deficit and small operating cash flows, so it may need external funding to continue.
- Scope
- Operations and product development
- Materiality
- high
Hi-Great Group Holding Co
Hi-Great Group Holding Co is a development-stage U.S. holding company that has shifted away from CBD oils and is now focused on licensing and distributing niche consumer health products. Its current business plan centers on an exclusive worldwide license tied to the KRAS gene concept, the sale of SellaCare organic longevity supplements, and a planned expansion into cosmetics and herbal-based consumer products.
−218,5 %
−66,9 %
−236,0 %
−46,6 %
0.12
0.00
| % | |
|---|---|
| Health supplements | 70% Organic longevity and wellness supplements marketed under the SellaCare license. |
| Licensing and IP-based initiatives | 10% Worldwide license arrangements and related commercialization concepts, including KRAS-related plans. |
| Cosmetics and personal care | 10% Planned expansion into cosmetic products using herbal oils and compounds. |
| Plant-based consumer products | 10% Finished consumer products built around specialty herbs and plant-based ingredients. |
The company appears to sell to consumers seeking longevity, wellness, and herbal supplement products, with a planned...
- Wellness supplement consumersprimary
Buy SellaCare longevity supplements for perceived health and longevity benefits.
- Natural and organic product buyersprimary
Purchase plant-based and specialty-herb products because they prefer natural ingredients.
- Cosmetics and personal care consumersemerging
Would buy herbal-oil and compound-based cosmetic products as the company expands.
- Commercial license and distribution partnerssecondary
Support product access, branding, and market reach through licensing or distribution arrangements.
The company is incorporated in Nevada and appears to operate primarily from the United States, with no disclosed...
- •Incorporated in Nevada, United States
- •Current operations appear U.S.-based
- •Worldwide license language suggests global commercialization intent
- •No disclosed country revenue breakdown in the excerpts
- •Geographic expansion would increase regulatory and distribution complexity
Management is trying to reposition the company around licensed wellness products, herbal consumer goods, and a future...
01
Commercialize licensed wellness productsshort-term
The company needs a clearer revenue engine than its prior CBD-related plan.
02
Expand into cosmeticsmedium-term
Cosmetics could broaden the addressable market and diversify product risk.
03
Build a sustainable multi-category platformmedium-term
Management wants multiple revenue streams to reduce dependence on one product line.
The company remains development-stage, with very limited sales and recurring losses, so execution and financing risk...
Commercialization failure
The business model depends on turning licensing and niche products into meaningful sales, which may not happen.
- Scope
- SellaCare, KRAS-related plan, cosmetics expansion
- Materiality
- high
Regulatory and product-claim risk
Supplements and cosmetics can face scrutiny over marketing claims, ingredients, and compliance.
- Scope
- Health supplements and cosmetic products
- Materiality
- medium
Dependence on third-party arrangements
The company relies on licenses, vendors, and service providers to execute its plan.
- Scope
- Licensing, distribution, professional services
- Materiality
- medium
Revenue recognition on product sales and licenses
Can shift revenue between periods and affect comparability
Equity issued for services
Affects operating expenses and shareholders' equity
Contingencies and estimates
Can change liabilities, expenses, and net loss
: 28.4.2026